What does the licensing of teplizumab mean for diabetes care?

Diabetes Obes Metab. 2023 Aug;25(8):2051-2057. doi: 10.1111/dom.15071. Epub 2023 Apr 24.
No abstract available

Keywords: autoantibodies; screening; teplizumab; type 1 diabetes.

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Autoantibodies
  • Diabetes Mellitus, Type 1* / drug therapy
  • Humans
  • Hypoglycemic Agents / adverse effects

Substances

  • teplizumab
  • Hypoglycemic Agents
  • Antibodies, Monoclonal, Humanized
  • Autoantibodies